| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0145-2126(84)90141-3 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0145212684901413?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0145212684901413?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 6201685 |
| P2093 | author name string | R. L. Momparler | |
| J. Bouchard | |||
| G. E. Rivard | |||
| N. Onetto | |||
| P2860 | cites work | DNA Methylation and Gene Function | Q28263722 |
| DNA methylation in the human γδβ-globin locus in erythroid and nonerythroid tissues | Q34251617 | ||
| Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia | Q40683687 | ||
| Specific DNA methylation sites in the vicinity of the chicken beta-globin genes | Q41700571 | ||
| Cellular differentiation, cytidine analogs and DNA methylation | Q42242732 | ||
| Use of restriction enzymes to study eukaryotic DNA methylation: II. The symmetry of methylated sites supports semi-conservative copying of the methylation pattern. | Q43769987 | ||
| DNA methylation controls the inducibility of the mouse metallothionein-I gene in lymphoid cells | Q51256105 | ||
| Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line. | Q54498862 | ||
| Effect of 5-azacytidine on DNA methylation in Ehrlich's ascites tumor cells | Q72621928 | ||
| Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia | Q72657219 | ||
| 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia | Q72682311 | ||
| Effect of 5-azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60) | Q72683682 | ||
| Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA | Q72693089 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| oncology | Q162555 | ||
| acute leukemia | Q976388 | ||
| DNA methylation | Q874745 | ||
| P304 | page(s) | 181-185 | |
| P577 | publication date | 1984-01-01 | |
| P1433 | published in | Leukemia Research | Q15716445 |
| P1476 | title | 5-AZA-2′-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation | |
| P478 | volume | 8 |
| Q33875819 | DNA methylation and cancer |
| Q41730013 | DNA methylation as a target for drug design |
| Q38040883 | DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences |
| Q34088403 | Decitabine in the treatment of myelodysplastic syndromes. |
| Q36284232 | Decitabine: a historical review of the development of an epigenetic drug |
| Q33678040 | Demethylating Agents in the Treatment of Cancer |
| Q52674783 | Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer. |
| Q36429559 | Epigenetic therapy with decitabine for myelodysplasia and leukemia |
| Q34768789 | Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies |
| Q35909283 | Investigational agents in myeloid disorders |
| Q39306981 | MYC-Master Regulator of the Cancer Epigenome and Transcriptome |
| Q37866296 | Pharmacokinetic evaluation of decitabine for the treatment of leukemia |
| Q44349057 | Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells |
| Q37634505 | Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents |
| Q37765469 | Therapy with azanucleosides for myelodysplastic syndromes |
Search more.